Simplifying Downstream Processing For Complex Biologics

By Kenneth Holbourn, Senior Director in Process Development at the FUJIFILM Biotechnologies UK site

Complex biologics are pushing downstream processing to its limits, introducing variability, scale challenges, and inefficiencies that can slow development timelines. Addressing these hurdles requires a more integrated approach—one that balances robustness with flexibility while maintaining product quality. Advances in purification strategies, process intensification, and smart system design are helping teams streamline workflows, reduce bottlenecks, and improve overall consistency.

By rethinking traditional unit operations and adopting technologies that enable continuous or simplified processing, organizations can better manage complex molecules and evolving pipelines. The result is greater control, improved yields, and more predictable outcomes across scales. For teams focused on accelerating development without compromising quality, exploring these strategies offers a clear path forward.

Discover how modern approaches are reshaping downstream processing and enabling more efficient biologics manufacturing.